At Supply Chain LIVE, Novartis’ operations lead Steffen Lang explained how the company gets radioligand therapies to patients within a 72 hour window
Mars’ Michelle Grogg discusses the company’s latest Impact Fund investment, which supports community health and disease prevention programmes
Formerly Head of Medical for Respiratory and Immunology at AstraZeneca UK, George Godfrey will lead Novo Nordisk UK’s medical and regulatory functions
Mars’ Michelle Grogg discusses the company’s latest Impact Fund investment, which supports community health and disease prevention programmes
At Supply Chain LIVE, Novartis’ operations lead Steffen Lang explained how the company gets radioligand therapies to patients within a 72 hour window
Nokia’s Shkumbin Hamiti explains how its Network as Code platform is helping BeeHealthy transform digital healthcare access with network-based verification
Pharma’s latest digital transformation wave is transitioning AI from isolated tool to core enabler— and is set to reshape the industry forever
All Articles
Andrea Haegebarth will join Novo Nordisk as SVP of Global Research, while Jacob Petersen will take on the role of Head of R&D External Innovation
David Niewolny, NVIDIA’s Director of Healthcare Business Development, unpacks the opportunities, barriers and prospects facing AI-native hospitals
As Chief Corporate Affairs and Sustainability Officer, Jonathan Rose will lead Bupa APAC’s communications, public affairs, and sustainability efforts
Sweden is aiming to ban PFAS chemicals in a bid to curb human exposure, with Minister Erik Slottner emphasising the move's benefits for public health
This week’s top stories include Roche’s Oregon expansion, TCS’ drug development platform, GSK’s hepatitis approval, and Danaher’s Chief HR appointment
Eli Lilly’s Zepbound has been linked with lower health costs, with CEO David Ricks saying the results show the value of investing in obesity treatment
Signed by Roche’s Finbarr Kerry and Sarah Collins of the UKHSA, the strategic partnership centres on diagnostics, health equity and pandemic preparedness
The acquisition of Precision highlights the company’s commitment to oncology innovation, says Jason Hammonds, McKesson’s President of Oncology
Heathre Moler will replace Georgeann Couchara as life science and diagnostics company Danaher’s next Chief Human Resources Officer from 1 October 2026
NHS England’s Dr Sue Mann calls HPV self-testing a “gamechanger” as almost 4 million women are offered kits to boost cervical screening uptake